Inhibiting NHEJ in HNSCC cell lines by the ligase IV inhibitor SCR130 has limited radiosensitizing effects

Abstract Radiotherapy (RT) is a relevant treatment for head and neck squamous cell carcinoma (HNSCC) patients but radioresistance, which depends on DNA damage response (DDR), restrains outcome. Therefore, manipulating DDR by small molecule inhibitors (SMI) is a promising treatment option. The main D...

Full description

Saved in:
Bibliographic Details
Main Authors: Laura S. Hildebrand, Tina Jost, Marion Schindler, Anja Derer, Gregor Fuhrmann, Rainer Fietkau, Luitpold V. Distel
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-03159-5
Tags: Add Tag
No Tags, Be the first to tag this record!